Search results
New COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
A promising vaccine approach to induce longer-lasting protective immunity against COVID-19
Medical Xpress· 3 days agoIn an ongoing, four-year collaboration, the team leveraged a novel vaccine platform to fuse the...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 4 days agoThe current predominant strain of COVID-19 should be a key consideration during the upcoming meeting...
COVID killed millions. Fauci’s House hearing shows we’re not ready for another pandemic.
The Courier Journal via Yahoo News· 1 day agoOne cannot minimize the pandemic and at the same time advocate that the virus was augmented in a...
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 6 hours agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...
FDA panel supports switch to JN.1 for fall COVID vaccines
Center for Infectious Disease Research and Policy· 2 days agoVaccine advisers to the Food and Drug Administration (FDA) today recommended switching the SARS-CoV-...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoInvivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced general alignment with the U.S. Food and Drug ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious ...
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 7 days agoInvivyd Inc. (NASDAQ: IVVD), a biopharmaceutical company, has announced an agreement with the U.S....
